DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
When do Delflex W/ Dextrose 2.5% In Plastic Container patents expire, and when can generic versions of Delflex W/ Dextrose 2.5% In Plastic Container launch?
Delflex W/ Dextrose 2.5% In Plastic Container is a drug marketed by Fresenius Medcl and is included in three NDAs.
The generic ingredient in DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER is calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate. There are two hundred and eighty-two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER?
- What are the global sales for DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER?
- What is Average Wholesale Price for DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER?
Summary for DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Finished Product Suppliers / Packagers: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER at DailyMed |
![DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER drug patent expirations Drug patent expirations by year for DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER](/p/graph/s/t/DELFLEX_W/_DEXTROSE_2.5%_IN_PLASTIC_CONTAINER-patent-expirations.png)